From the investor call today, it appears that that rate of cash burn will continue until FDA submission in around 4-8 weeks, then they will scale down costs pending a number of outcomes (revenues, FDA approval, wider regulatory approvals etc).
They're walking a tight line.
I think its pretty clear still that everything turns on FDA. Hopefully approved by July-August.
If FDA obtained I think I'd be fairly relaxed about them raising/sourcing capital and continuing to spend. If no FDA approval its probably fu*t.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AYA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
-0.030(12.0%) |
Mkt cap ! $17.31M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.0¢ | 22.0¢ | $4.612K | 19.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 83865 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 12000 | 2 |
View Market Depth
| Last trade - 14.27pm 28/06/2024 (20 minute delay) ? |
| AYA (ASX) Chart |